NCC Global | Revolutionizes Market Entry at WHX Dubai 2026 with Innovative "Zero-Capex" Partnership Model

DUBAI, Feb 12, 2026 — NCC Medical（诺诚电生理）concluded a highly successful showcase at WHX Dubai 2026. Beyond presenting its comprehensive neurophysiology portfolio, the company made waves by introducing a strategic commercial policy designed to empower g

Cutting-Edge Portfolio on Display
NCC Medical presented its full suite of neuro-diagnostic and monitoring solutions, catering to the evolving needs of modern hospitals.

Intraoperative Neuromonitoring (IONM): The flagship Cynapse IONM and Smart IONM systems highlighted our commitment to patient safety during complex surgeries.
Clinical Diagnostics: Advanced EEG, EMG, and Wireless PSG systems demonstrated our leading position in neuro-diagnostic technology.
Rehabilitation & Research: The Wireless Surface EMG garnered praise for its portability and high-fidelity signal acquisition.

Strategic Initiative: "Buy Consumables, Get Free IONM System"
To accelerate clinical adoption and support our partners, NCC Medical officially launched its "Buy Consumables, Get Free IONM System" program at the event.

Lowering Barriers: This initiative is specifically designed to eliminate the heavy upfront capital expenditure (CAPEX) for equipment.
Accelerated ROI: By shifting to an OPEX-friendly model, distributors can enter the market faster and focus on clinical service and market penetration, ensuring a more rapid return on investment.

Global Partnership Opportunities While the Middle East remains a key focus, the overwhelming interest from international delegates underscores the global demand for NCC’s solutions. NCC Medical is currently seeking professional distributors worldwide. We provide our partners with robust technical support, comprehensive training, and industry-leading commercial incentives.